Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II study assessing OTX-TKI in Australia

Trial Profile

A phase II study assessing OTX-TKI in Australia

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Axitinib (Primary)
  • Indications Wet age-related macular degeneration
  • Focus Therapeutic Use
  • Sponsors Ocular Therapeutix
  • Most Recent Events

    • 27 Sep 2022 According to an Ocular Therapeutix media release, the company plans to initiate the trial in the third quarter of 2023. The initiation will be based on the results from the phase 1 study and the companys discussion with FDA regarding potential future clinical trial requirements.
    • 11 Feb 2022 According to an Ocular Therapeutix media release, the company plans to dose first patient in this trial shortly.
    • 12 Nov 2020 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top